- Home
- UNTY vs FDMT Comparison
UNTY vs FDMT Comparison
Compare UNTY & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UNTY | FDMT |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.4M | 455.4M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UNTY | FDMT |
|---|---|---|
| Price | $53.10 | $7.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $59.67 | $30.33 |
| AVG Volume (30 Days) | 46.7K | ★ 1.2M |
| Earning Date | 01-12-2026 | 02-27-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | ★ 35.12 | N/A |
| EPS | ★ 5.27 | N/A |
| Revenue | ★ $121,970,000.00 | $120,000.00 |
| Revenue This Year | $24.41 | $21,181.08 |
| Revenue Next Year | $11.16 | $162.43 |
| P/E Ratio | $9.78 | ★ N/A |
| Revenue Growth | 20.98 | ★ 605.88 |
| 52 Week Low | $36.65 | $2.24 |
| 52 Week High | $57.24 | $12.34 |
Technical Indicators
Market Signals| Indicator | UNTY | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 34.50 |
| Support Level | $49.65 | $6.96 |
| Resistance Level | $52.77 | $8.06 |
| Average True Range (ATR) | 1.79 | 0.53 |
| MACD | -0.34 | -0.08 |
| Stochastic Oscillator | 49.72 | 12.99 |
Price Performance
Historical ComparisonAbout UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.